Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Anika Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$5.12M. For fiscal 2025 it was -$11.05M. The highest annual figure on record is $61.45M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.05M | – |
| FY2024 | Dec 31, 2024 | -$5.10M | -704.4% |
| FY2023 | Dec 31, 2023 | $844.00K | -77.0% |
| FY2022 | Dec 31, 2022 | $3.67M | +40.3% |
| FY2021 | Dec 31, 2021 | $2.62M | – |
| FY2020 | Dec 31, 2020 | -$28.32M | -182.7% |
| FY2019 | Dec 31, 2019 | $34.25M | +57.5% |
| FY2018 | Dec 31, 2018 | $21.75M | -52.4% |
| FY2017 | Dec 31, 2017 | $45.73M | -9.6% |
| FY2016 | Dec 31, 2016 | $50.61M | +5.1% |
| FY2015 | Dec 31, 2015 | $48.13M | -21.7% |
| FY2014 | Dec 31, 2014 | $61.45M | +88.4% |
| FY2013 | Dec 31, 2013 | $32.61M | +65.4% |
| FY2012 | Dec 31, 2012 | $19.72M | +41.2% |
| FY2011 | Dec 31, 2011 | $13.97M | +85.3% |
| FY2010 | Dec 31, 2010 | $7.54M | +34.9% |
| FY2009 | Dec 31, 2009 | $5.59M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.95M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.49M | – |
| Q4 FY2025 | Dec 31, 2025 | $646.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.18M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.28M | – |
| Q4 FY2024 | Dec 31, 2024 | -$705.00K | -102.9% |
| Q3 FY2024 | Sep 30, 2024 | -$81.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.51M | – |
| Q4 FY2023 | Dec 31, 2023 | $24.70M | +50.6% |
| Q3 FY2023 | Sep 30, 2023 | -$7.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.63M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.55M | – |
| Q4 FY2022 | Dec 31, 2022 | $16.40M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.80M | -546.0% |
| Q2 FY2022 | Jun 30, 2022 | -$3.38M | -136.8% |
| Q1 FY2022 | Mar 31, 2022 | -$3.55M | -382.5% |
| Q4 FY2021 | Dec 31, 2021 | -$9.12M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.30M | – |
| Q2 FY2021 | Jun 30, 2021 | $9.18M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.26M | -82.3% |
| Q4 FY2020 | Dec 31, 2020 | -$17.95M | -473.9% |
| Q3 FY2020 | Sep 30, 2020 | -$7.93M | -165.8% |
| Q2 FY2020 | Jun 30, 2020 | -$9.54M | -180.0% |
| Q1 FY2020 | Mar 31, 2020 | $7.09M | +29.4% |
| Q4 FY2019 | Dec 31, 2019 | $4.80M | -50.8% |
| Q3 FY2019 | Sep 30, 2019 | $12.05M | +40.5% |
| Q2 FY2019 | Jun 30, 2019 | $11.92M | +5.9% |
| Q1 FY2019 | Mar 31, 2019 | $5.48M | – |
| Q4 FY2018 | Dec 31, 2018 | $9.76M | +0.3% |
| Q3 FY2018 | Sep 30, 2018 | $8.57M | -16.5% |
| Q2 FY2018 | Jun 30, 2018 | $11.25M | -36.6% |
| Q1 FY2018 | Mar 31, 2018 | -$7.83M | -197.8% |
| Q4 FY2017 | Dec 31, 2017 | $9.73M | -23.6% |
| Q3 FY2017 | Sep 30, 2017 | $10.27M | -25.0% |
| Q2 FY2017 | Jun 30, 2017 | $17.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.74M | – |
| Q3 FY2016 | Sep 30, 2016 | $13.69M | – |
See a number that looks wrong?